The 54th annual meeting of the European Association for the Study of the Liver (EASL) will have dozens of exciting presentations, but readouts from Alnylam Pharmaceuticals (NASDAQ: ALNY) and Intercept Pharmaceuticals (NASDAQ: ICPT) will probably receive the most attention. Here's why.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,